WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. Our leading global services can reduce discovery and development time, and lower the cost of development through efficient and tailor-made outsourcing solutions. WuXi AppTec established a representative office in Israel to advance our mission of helping entrepreneurs in the global life sciences industry to realize their dreams of developing innovative products to benefit the world’s patients and of providing Israeli clients with the highest level of service and convenience.

SmartWave Medical develops a new treatment approach for atrial fibrillation based on an implantable atrial defibrillator. This innovative IAD is designed to automatically detect and terminate AF episodes immediately upon their onset by delivering tolerable defibrillation pulses. Thanks to the application of a new and unique waveform, the device should operate without causing unwanted patient discomfort.

Omer Therapeutics is a small, privately owned company established in June 2011, involved in developing of a preventive treatment for allergic disorders. The core technology of the company is based on the research conducted by Prof. Shoseyov from the faculty of agriculture at the Hebrew University. The company’s current focus is on developing an intranasal spray for treating Allergic Rhinitis (AR). In addition, the company has a broad pipeline for future development including treatments for asthma, skin barriers malfunctions and food allergy.

The Health Administration Program - an innovative joint endeavor of the Faculty of Management and the Faculty of Medicine - trains managers for the Israeli healthcare sector. The comprehensive curriculum combines study of management theory, techniques and tools, and their application to the unique problems inherent in health systems management in general and the challenges facing the Israeli health system in particular. This twofold emphasis prepares graduates to fill a broad spectrum of management roles within a variety of healthcare frameworks and organizations.

Responsible for the clinical aspects of the company activities, leading new business opportunities and working on ongoing business development activities. Also participating in CollPlant extended management team

Responsible for the medical aspects of the company activities, a partner in choosing new molecules, in giving medical guidance to pre-clinical development, and guiding the medical aspects of the clinical trials, participating in BiolineRx extended management team

Managing drug development projects in various areas, including but not limited to: CMC, preclinical and clinical aspects

Accompany all the medical aspects of projects including but not limited to: screening, in-licensing, ongoing projects in different stages of development, out-licensing